Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Biodetection

    USAMRIID Contract for Shark Inoculation with Vaccinia Virus

    By Global Biodefense StaffJanuary 7, 2013
    Share
    Facebook LinkedIn Reddit Email

    Nurse SharkThe United States Army Medical Research of Infectious Disease (USAMRIID) Diagnostic Systems Division has awarded a sole source contract to the University of Maryland, Baltimore to inoculate sharks with recombinant vaccinia virus proteins.

    The overall goal of the research is to create more rugged immunodiagnostic assays using single domain antibodies (sdAbs). While traditional antibody-based tests use canonical antibodies (cAbs), whose relative fragility requires a cold chain for storage and transportation, sdAbs have a much higher thermostability while maintaining comparable affinities and immunogenicity.

    Sharks, llamas and other camelids are the only known species to produce such sdAbs.  Under the research award, sharks will be inoculated with recombinant vaccinia virus protein L1 to stimulate sdAb production against L1.

    The contract includes a one-year base period with four twelve-month option periods. 

    Related Resource: Design and testing of a thermostable platform for multimerization of single-domain antibodies (US Army RDECOM, August 2012 .pdf)

    Awards Ruggedized Smallpox Thermostability USAMRIID
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleFDA Initiative to Speed Medical Device Development
    Next Article Chemical Warfare Decontamination System RFP

    Related Stories

    New Method Improves Quantification of Ricin in Complex Matrices

    September 20, 2023

    Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

    September 20, 2023

    Biomarkers for Detection of Exposure to Nitrogen Mustards

    September 20, 2023

    Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant

    September 17, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    Oct 17
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Dispensing and Administration of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.